Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). PhoenixBio Co's share price for the quarter that ended in Mar. 2026 was 円440. PhoenixBio Co's Shares Outstanding (EOP) for the quarter that ended in Mar. 2026 was 4 Mil. Therefore, PhoenixBio Co's market cap for the quarter that ended in Mar. 2026 was 円1,791 Mil.
PhoenixBio Co's quarterly market cap
increased
from Sep. 2025 (円1,656 Mil) to Dec. 2025 (円1,966 Mil) but then
declined
from Dec. 2025 (円1,966 Mil) to Mar. 2026 (円1,791 Mil).
PhoenixBio Co's annual market cap
declined
from Mar. 2024 (円1,941 Mil) to Mar. 2025 (円1,494 Mil) but then
increased
from Mar. 2025 (円1,494 Mil) to Mar. 2026 (円1,791 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. PhoenixBio Co's Enterprise Value for Today is 円755 Mil.
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
PhoenixBio Co Market Cap Related Terms
PhoenixBio Co Market Cap Historical Data
* Premium members only.
The historical data trend for PhoenixBio Co's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6190 vs VRTX, REGN, RVMD: Market Cap Comparison
For the Biotechnology subindustry, PhoenixBio Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PhoenixBio Co Market Cap vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, PhoenixBio Co's Market Cap distribution charts can be found below:
* The bar in red indicates where PhoenixBio Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
PhoenixBio Co's Market Cap for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PhoenixBio Co (TSE:6190) has a Market Cap of 円1,416 Mil as of Aug. 08, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PhoenixBio Co and its competitors. According to the industry distribution chart, PhoenixBio Co ranks #1216 out of 1423 companies in the Biotechnology industry, placing it in the top 85.5%.
Is PhoenixBio Co's Market Cap too high?
PhoenixBio Co's current Market Cap is 円1,416 Mil. Based on the distribution chart, PhoenixBio Co ranks #1216 out of 1423 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, PhoenixBio Co has a GF Score™ of 51/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does PhoenixBio Co's Market Cap compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, PhoenixBio Co ranks #1216 out of 1423 companies for Market Cap. This places PhoenixBio Co in the lower half of its industry. The industry median Market Cap is 116.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Biotechnology company?
The median Market Cap among Biotechnology companies is 116.70, based on 1,423 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on PhoenixBio Co and its competitors. For the Biotechnology industry, the median Market Cap is 116.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PhoenixBio Co's current Market Cap is 円1,416 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PhoenixBio Co stock overvalued right now?
Based on GuruFocus' analysis, PhoenixBio Co (TSE:6190) is currently considered Fairly Valued. The stock's GF Value™ is 円354.02, compared to a current price of 円348.00 — trading 1.7% below its estimated fair value. The current Market Cap is 円1,416 Mil. PhoenixBio Co's overall GF Score™ is 51/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For PhoenixBio Co (TSE:6190), the current Market Cap is 円1,416 Mil as of Aug. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PhoenixBio Co (TSE:6190) Overvalued in 2026?
Based on GuruFocus' analysis, PhoenixBio Co stock appears to be undervalued.
The current stock price of 円348.00 is trading 1.7% below its estimated GF Value™ of 円354.02.
GuruFocus considers PhoenixBio Co to be Fairly Valued.
Key valuation signals for TSE:6190:
Market Cap: 円1,416 Mil
GF Value™: 円354.02 vs. price of 円348.00 (1.7% below fair value)
No single metric tells the full story. See the TSE:6190 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PhoenixBio Co Ltd conducts study services for drug discovery and early development. It provides outsourcing services for drug development. The Company uses PXB-Mouse to conduct the study. Its services include pharmacokinetics-related tests, safety tests, and hepatitis virus (HBV / HCV) related drug efficacy tests. Geographically, the company generates the majority of its revenue from USA.
51GF Score
Get the complete analysis for TSE:6190
Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6190 has been successfully added to your 
